-
Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 3 -- Ex vivo imaging: data processing, comparisons with microscopy, and tractography
Authors:
Kurt G Schilling,
Amy FD Howard,
Francesco Grussu,
Andrada Ianus,
Brian Hansen,
Rachel L C Barrett,
Manisha Aggarwal,
Stijn Michielse,
Fatima Nasrallah,
Warda Syeda,
Nian Wang,
Jelle Veraart,
Alard Roebroeck,
Andrew F Bagdasarian,
Cornelius Eichner,
Farshid Sepehrband,
Jan Zimmermann,
Lucas Soustelle,
Christien Bowman,
Benjamin C Tendler,
Andreea Hertanu,
Ben Jeurissen,
Marleen Verhoye,
Lucio Frydman,
Yohan van de Looij
, et al. (33 additional authors not shown)
Abstract:
Preclinical diffusion MRI (dMRI) has proven value in methods development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly being used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages that facilitat…
▽ More
Preclinical diffusion MRI (dMRI) has proven value in methods development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly being used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages that facilitate high spatial resolution and high signal-to-noise ratio (SNR) images, cutting-edge diffusion contrasts, and direct comparison with histological data as a methodological validation. However, there are a number of considerations that must be made when performing ex vivo experiments. The steps from tissue preparation, image acquisition and processing, and interpretation of results are complex, with many decisions that not only differ dramatically from in vivo imaging of small animals, but ultimately affect what questions can be answered using the data. This work concludes a 3-part series of recommendations and considerations for preclinical dMRI. Herein, we describe best practices for dMRI of ex vivo tissue, with a focus on image pre-processing, data processing and model fitting, and tractography. In each section, we attempt to provide guidelines and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should lie. We end by providing guidelines on code sharing and data sharing, and point towards open-source software and databases specific to small animal and ex vivo imaging.
△ Less
Submitted 24 October, 2024;
originally announced November 2024.
-
Considerations and recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 2 -- Ex vivo imaging: added value and acquisition
Authors:
Kurt G Schilling,
Francesco Grussu,
Andrada Ianus,
Brian Hansen,
Amy FD Howard,
Rachel L C Barrett,
Manisha Aggarwal,
Stijn Michielse,
Fatima Nasrallah,
Warda Syeda,
Nian Wang,
Jelle Veraart,
Alard Roebroeck,
Andrew F Bagdasarian,
Cornelius Eichner,
Farshid Sepehrband,
Jan Zimmermann,
Lucas Soustelle,
Christien Bowman,
Benjamin C Tendler,
Andreea Hertanu,
Ben Jeurissen,
Lucio Frydman,
Yohan van de Looij,
David Hike
, et al. (32 additional authors not shown)
Abstract:
The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher signal-to-noise ratio and spatial resolution compared to in vivo studies, and enabling more advanced diffusion cont…
▽ More
The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non-invasive characterization of tissue, ex vivo dMRI is increasingly used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher signal-to-noise ratio and spatial resolution compared to in vivo studies, and enabling more advanced diffusion contrasts. Another major advantage of ex vivo dMRI is the direct comparison with histological data as a methodological validation. However, there are a number of considerations that must be made when performing ex vivo experiments. The steps from tissue preparation, image acquisition and processing, and interpretation of results are complex, with decisions that not only differ dramatically from in vivo imaging of small animals, but ultimately affect what questions can be answered using the data. This work represents "Part 2" of a 3-part series of recommendations and considerations for preclinical dMRI. We describe best practices for dMRI of ex vivo tissue, with a focus on the value that ex vivo imaging adds to the field of dMRI and considerations in ex vivo image acquisition. We give general considerations and foundational knowledge that must be considered when designing experiments. We describe differences in specimens and models and discuss why some may be more or less appropriate for different studies. We then give guidelines for ex vivo protocols, including tissue fixation, sample preparation, and MR scanning. In each section, we attempt to provide guidelines and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should lie. An overarching goal herein is to enhance the rigor and reproducibility of ex vivo dMRI acquisitions and analyses, and thereby advance biomedical knowledge.
△ Less
Submitted 24 October, 2024; v1 submitted 27 September, 2022;
originally announced September 2022.
-
Considerations and Recommendations from the ISMRM Diffusion Study Group for preclinical diffusion MRI: Part 1 -- In vivo small-animal imaging
Authors:
Ileana O Jelescu,
Francesco Grussu,
Andrada Ianus,
Brian Hansen,
Rachel L C Barrett,
Manisha Aggarwal,
Stijn Michielse,
Fatima Nasrallah,
Warda Syeda,
Nian Wang,
Jelle Veraart,
Alard Roebroeck,
Andrew F Bagdasarian,
Cornelius Eichner,
Farshid Sepehrband,
Jan Zimmermann,
Lucas Soustelle,
Christien Bowman,
Benjamin C Tendler,
Andreea Hertanu,
Ben Jeurissen,
Marleen Verhoye,
Lucio Frydman,
Yohan van de Looij,
David Hike
, et al. (32 additional authors not shown)
Abstract:
Small-animal diffusion MRI (dMRI) has been used for methodological development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. The steps from animal setup and monitoring, to acquisition, analysis, and interpretation are complex, with many decisions that may ultimately affect what questions can be answered using the resultant data. This work aims…
▽ More
Small-animal diffusion MRI (dMRI) has been used for methodological development and validation, characterizing the biological basis of diffusion phenomena, and comparative anatomy. The steps from animal setup and monitoring, to acquisition, analysis, and interpretation are complex, with many decisions that may ultimately affect what questions can be answered using the resultant data. This work aims to present selected recommendations and guidelines from the diffusion community, on best practices for preclinical dMRI of in vivo animals. We describe the general considerations and foundational knowledge that must be considered when designing experiments. We briefly describe differences in animal species and disease models and discuss why some may be more or less appropriate for different studies. We then give guidelines for in vivo acquisition protocols, including decisions on hardware, animal preparation, and imaging sequences, followed by advice for data processing including pre-processing, model-fitting, and tractography. Finally, we provide an online resource which lists publicly available preclinical dMRI datasets and software packages, to promote responsible and reproducible research. In each section, we attempt to provide guides and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should focus. While we mainly cover the central nervous system (on which most preclinical dMRI studies are focused), we also provide, where possible and applicable, recommendations for other organs of interest. An overarching goal herein is to enhance the rigor and reproducibility of small animal dMRI acquisitions and analyses, and thereby advance biomedical knowledge.
△ Less
Submitted 21 November, 2024; v1 submitted 26 September, 2022;
originally announced September 2022.
-
Inflammation-driven glial alterations in the cuprizone mouse model probed with diffusion-weighted magnetic resonance spectroscopy at 11.7 T
Authors:
Guglielmo Genovese,
Marco Palombo,
Mathieu D. Santin,
Julien Valette,
Clémence Ligneul,
Marie-Stéphane Aigrot,
Nasteho Abdoulkader,
Dominique Langui,
Aymeric Millecamps,
Anne Baron-Van Evercooren,
Bruno Stankoff,
Stéphane Lehericy,
Alexandra Petiet,
Francesca Branzoli
Abstract:
Inflammation of brain tissue is a complex response of the immune system to the presence of toxic compounds or to cell injury, leading to a cascade of pathological processes that include glial cell activation. Noninvasive magnetic resonance imaging markers of glial reactivity would be very useful for in vivo detection and monitoring of inflammation processes in the brain, as well as for evaluating…
▽ More
Inflammation of brain tissue is a complex response of the immune system to the presence of toxic compounds or to cell injury, leading to a cascade of pathological processes that include glial cell activation. Noninvasive magnetic resonance imaging markers of glial reactivity would be very useful for in vivo detection and monitoring of inflammation processes in the brain, as well as for evaluating the efficacy of personalized treatments. Due to their specific location in glial cells, myo-inositol (mIns) and choline compounds (tCho) seem the best candidates for probing glial-specific intra-cellular compartments. However, their concentrations quantified using conventional proton magnetic resonance spectroscopy (MRS) are not specific for inflammation. In contrast, it has been recently suggested that mIns intra-cellular diffusion, measured using diffusion-weighted MRS (DW-MRS) in a mouse model of reactive astrocytes, could be a specific marker of astrocytic hypertrophy. In order to evaluate the specificity of both mIns and tCho diffusion to inflammation-driven glial alterations, we performed DW-MRS in the corpus callosum of cuprizone-fed mice after 6 weeks of intoxication and evaluated the extent of astrocytic and microglial alterations using immunohistochemistry. Both mIns and tCho apparent diffusion coefficients were significantly elevated in cuprizone-fed mice compared to control mice, while histologic evaluation confirmed the presence of severe inflammation. Additionally, mIns and tCho diffusion showed, respectively, strong and moderate correlations with histological measures of astrocytic and microglial area fractions, confirming DW-MRS as a promising tool for specific detection of glial changes under pathological conditions.
△ Less
Submitted 16 July, 2020;
originally announced July 2020.
